Myxedema coma risk factors: Difference between revisions

Jump to navigation Jump to search
Line 20: Line 20:
*[[Gastrointestinal bleeding]]
*[[Gastrointestinal bleeding]]
*[[Trauma]]
*[[Trauma]]
*Metabolic disturbances
*Metabolic disorders
**[[Hypoglycemia]]
**[[Hypoglycemia]]
**[[Hyponatremia]]
**[[Hyponatremia]]

Revision as of 13:47, 18 October 2017

Myxedema coma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myxedema coma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myxedema coma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myxedema coma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myxedema coma risk factors

CDC on Myxedema coma risk factors

Myxedema coma risk factors in the news

Blogs on Myxedema coma risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Myxedema coma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common risk factors in the development of myxedema coma include hypothermia, cerebrovascular accidents, congestive heart failure, infections, drugs,gastrointestinal bleeding, trauma, and electrolyte disturbances.

Risk factors

Common risk factors in the development of myxedema coma include:[1][2][3]

References

  1. Mazonson PD, Williams ML, Cantley LK, Dalldorf FG, Utiger RD, Foster JR (1984). "Myxedema coma during long-term amiodarone therapy". Am. J. Med. 77 (4): 751–4. PMID 6486153.
  2. Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A (2010). "A forgotten but important risk factor for severe hyponatremia: myxedema coma". Clinics (Sao Paulo). 65 (4): 447–8. doi:10.1590/S1807-59322010000400015. PMC 2862668. PMID 20454504.
  3. Kwaku MP, Burman KD (2007). "Myxedema coma". J Intensive Care Med. 22 (4): 224–31. doi:10.1177/0885066607301361. PMID 17712058.